The ACIP statement (“Human Rabies Prevention-United States, 2008, Recommendations of the Advisory Committee on Immunization Practices”) was published in MMWR on May 23, 2008. This document updated the status of rabies and anti-rabies biologics in the United States. To view this document, go to www.cdc.gov/mmwr/PDF/rr/rr5703.pdf.
In March 2010, ACIP eliminated the fifth dose of vaccine given post-exposure to previously unvaccinated persons with no immunosuppression. To view these recommendations, go to www.cdc.gov/mmwr/pdf/rr/rr5902.pdf.
In May 2022, ACIP eliminated the third dose of vaccine given in the primary series for pre-exposure prophylaxis and introduced updated risk categories with customized recommendations for long-term follow up after completion of the 2-dose primary series. To view this document, visit www.cdc.gov/mmwr/volumes/71/wr/pdfs/mm7118a2-H.pdf.